Advisors Capital Management LLC Buys Shares of 6,507 HCA Healthcare, Inc. $HCA

Advisors Capital Management LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 6,507 shares of the company's stock, valued at approximately $2,537,000.

Several other institutional investors have also added to or reduced their stakes in HCA. BlackRock Inc. purchased a new position in HCA Healthcare during the 2nd quarter worth approximately $5,069,974,000. Norges Bank acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new stake in HCA Healthcare during the fourth quarter worth about $374,037,000. Viking Global Investors LP lifted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after acquiring an additional 690,773 shares during the period. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company's stock worth $309,686,000 after purchasing an additional 649,058 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $429.08 on Friday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The business's 50-day simple moving average is $397.16 and its 200 day simple moving average is $444.14. The stock has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a price-to-earnings-growth ratio of 1.41 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company posted $6.84 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 10.45%.

Analysts Set New Price Targets

A number of analysts have recently commented on HCA shares. Stephens cut their price objective on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Royal Bank Of Canada reissued an "outperform" rating and set a $435.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Truist Financial lowered their price objective on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Finally, Oppenheimer decreased their target price on HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating on the stock in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source